Posard Matthew L. 4
4 · Talis Biomedical Corp · Filed Jun 12, 2023
Insider Transaction Report
Form 4
Posard Matthew L.
Director
Transactions
- Award
Stock option (right to buy)
2023-06-09+95,000→ 95,000 totalExercise: $0.50Exp: 2033-06-09→ Common Stock (95,000 underlying)
Footnotes (1)
- [F1]1/12th of the shares subject to the option shall vest monthly over one year from the vesting commencement date.